These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 18656415)

  • 1. [Response of F. Leung, J.-J. Terzibachian and D. Riethmuller to the article of M. Saim et al. Malignant mixed Müllerian tumor of the uterus following tamoxifen for breast cancer: case report. Gynecol Obstet Fertil 2008;36:166-8].
    Leung F; Terzibachian JJ; Riethmuller D
    Gynecol Obstet Fertil; 2008; 36(7-8):828-9. PubMed ID: 18656415
    [No Abstract]   [Full Text] [Related]  

  • 2. Malignant mixed Müllerian tumor of the uterus associated with tamoxifen therapy for breast cancer.
    Magnani KK; Dubey S; Rai S
    Indian J Pathol Microbiol; 2010; 53(4):886-7. PubMed ID: 21045469
    [No Abstract]   [Full Text] [Related]  

  • 3. [Malignant mixed müllerian tumor of the uterus following tamoxifen for breast cancer: case report].
    Saim M; Cote JF; Morel O; Malartic C; Akerman G; Gray F; Barranger E
    Gynecol Obstet Fertil; 2008 Feb; 36(2):166-168. PubMed ID: 18249575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased risk of malignant mullerian tumor of the uterus among women with breast cancer treated by tamoxifen.
    Bouchardy C; Verkooijen HM; Fioretta G; Sappino AP; Vlastos G
    J Clin Oncol; 2002 Nov; 20(21):4403. PubMed ID: 12409344
    [No Abstract]   [Full Text] [Related]  

  • 5. [Tamoxifen in the adjuvant setting for breast cancer: Reflexions about the risk of uterine carcinosarcoma].
    Leung F; Terzibachian JJ; Govyadovskiy A; Bourtembourg A; Maillet R; Riethmuller D
    Gynecol Obstet Fertil; 2009 May; 37(5):447-51. PubMed ID: 19394886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Mixed mullerian tumours of the endometrium. Four cases developed while on tamoxifen treatment].
    Walker F; Genestie C
    Gynecol Obstet Fertil; 2004 Dec; 32(12):1091-2. PubMed ID: 15589790
    [No Abstract]   [Full Text] [Related]  

  • 7. Endometrial mixed Müllerian tumor with heterologous elements following tamoxifen therapy for breast cancer: a case report and literature review.
    Kaleli S; Calay Z; Altinok T; Kösebay D
    Eur J Obstet Gynecol Reprod Biol; 2002 Mar; 101(2):204-8. PubMed ID: 11858901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carcinosarcoma of the uterus with melanocytic differentiation.
    Kajo K; Zubor P; Spacek J; Ryska A
    Pathol Res Pract; 2007; 203(10):753-8. PubMed ID: 17656038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malignant mixed Mullerian tumour of uterus secondary to tamoxifen therapy for hormone responsive breast cancer.
    Gupta M; Kiruthiga KG
    BMJ Case Rep; 2015 Jun; 2015():. PubMed ID: 26123463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnetic resonance imaging findings of tamoxifen-associated uterine Müllerian adenosarcoma: a case report.
    Soh E; Eleti A; Jimenez-Linan M; Arends MJ; Latimer J; Sala E
    Acta Radiol; 2008 Sep; 49(7):848-51. PubMed ID: 19143068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carcinosarcoma, endometrial intraepithelial carcinoma and endometriosis after tamoxifen therapy in breast cancer.
    Friedrich M; Villena-Heinsen C; Mink D; Bonkhoff H; Schmidt W
    Eur J Obstet Gynecol Reprod Biol; 1999 Jan; 82(1):85-7. PubMed ID: 10192492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sonography and MRI of tamoxifen-associated müllerian adenosarcoma of the uterus.
    Chourmouzi D; Boulogianni G; Zarampoukas T; Drevelengas A
    AJR Am J Roentgenol; 2003 Dec; 181(6):1673-5. PubMed ID: 14627594
    [No Abstract]   [Full Text] [Related]  

  • 13. Post-irradiation carcinosarcoma of uterus--a case report.
    Sharma AB; Pukhrambam G; Laishram S
    Indian J Pathol Microbiol; 2006 Oct; 49(4):559-61. PubMed ID: 17183854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ureteral mullerian carcinosarcoma (mixed mullerian tumor) associated with endometriosis occurring in a patient with a concentrated soy isoflavones supplementation.
    Noel JC; Anaf V; Fayt I; Wespes E
    Arch Gynecol Obstet; 2006 Oct; 274(6):389-92. PubMed ID: 16847632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of medroxyprogesterone acetate in the treatment of Müllerian adenosarcoma: a case report.
    Hines BJ; Porges RF; Mittal K; Muggia FM; Curtin JP
    Gynecol Oncol; 2002 Apr; 85(1):192-5. PubMed ID: 11925144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What is the impact of tamoxifen on radiation-induced fibrosis in patients receiving breast-conserving therapy.
    Koc M
    J Clin Oncol; 2007 Dec; 25(36):5841; author reply 5844-5. PubMed ID: 18089889
    [No Abstract]   [Full Text] [Related]  

  • 17. Uterine inversion by a mixed müllerian tumor of the corpus.
    Tjalma WA; Naik R; Monaghan JM; De Barros Lopes A
    Int J Gynecol Cancer; 2003; 13(6):894-7. PubMed ID: 14675330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary peritoneal carcinosarcoma (malignant mixed mullerian tumor): Report of a case with five-year disease free survival after surgery and chemoradiation and a review of literature.
    Ko ML; Jeng CJ; Huang SH; Shen J; Tzeng CR; Chen SC
    Acta Oncol; 2005; 44(7):756-60. PubMed ID: 16227168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does hormonal therapy decrease tamoxifen associated hot flashes?
    Barton DL; Loprinzi CL
    Breast Cancer Res Treat; 2009 Aug; 116(3):529-30. PubMed ID: 19205876
    [No Abstract]   [Full Text] [Related]  

  • 20. Endometrial müllerian carcinosarcoma after cessation of tamoxifen therapy for breast cancer.
    Sasco AJ; Raffi F; Satgé D; Goburdhun J; Fallouh B; Leduc B
    Int J Gynaecol Obstet; 1995 Mar; 48(3):307-10. PubMed ID: 7781875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.